NICE make Greenlight PVP the preferred UK option
Posted , 6 users are following.
The case for adopting GreenLight XPS for treating benign prostatic hyperplasia is supported in non-high-risk patients. Please see the guidance for details.
We estimate that around 13,600 people with benign prostatic hyperplasia are eligible to have GreenLight XPS. Uptake of GreenLight XPS will be steady from year 2 onwards with around 6,800 people having the procedure each year.
Savings range from £1.3 million when 36% of procedures with GreenLight XPS are done as day cases, to as much as £3.2 million when 70% are done as day cases.
Based on 53% of GreenLight XPS procedures being done as day cases, the guidance is estimated to save the NHS around £2.3 million per year (or £4,200 per 100,000 people
https://www.nice.org.uk/guidance/mtg29/resources/resource-impact-report-2541401533
0 likes, 26 replies
rogcal derek76
Posted
The senior Uro surgeon that had campaigned to get the Trust to buy into GL a couple of years previously was furious. He'd trained up all the other Uro surgeons in its use and for two years it was used successfully and with great savings in patient aftercare costs but the "bean counters" claimed it had turned out to be more expensive overall than the TURP procedure.
I was lucky enough to get referred to Addenbrookes where everything is state of the art whereas Lincolnshire is still in the dark ages with TURP for BPH and open prostatectomy for prostate removal. Talk about the dark ages!